FTC Files Complaints Against Weight-Loss Pill Marketers

The Federal Trade Commission (FTC) has filed complaints in four separate cases alleging that weight-loss and weight-control claims were not supported by competent and reliable scientific evidence. Marketers of the four products (Xenadrine EFX, CortiSlim, TrimSpa, and One-A-Day WeightSmart) have settled with the FTC, surrendered cash and other assets worth at least $25 million, and agreed to limit their future advertising claims. "You won't find weight loss in a bottle of pills that claims it has the latest scientific breakthrough or miracle ingredient," said FTC Chairman Deborah Platt Majoras. "Paying for fad science is a good way to lose cash, not pounds."

• Read the FTC Press Release